COVID-19: United Kingdom records lowest number of coronavirus deaths since early October

No Evidence Of Increased Blood Clot Risk From Vaccine Says AstraZeneca

The German government said earlier on Monday that it was suspending the use of AstraZeneca's coronavirus vaccine over reports of unsafe blood clots in connection with the shot. Danish health authorities said the suspension would last for at least two weeks while the cases were investigated, even as they noted that "at present, it can not be concluded whether there is a link between the vaccine and the blood clots".

"A careful review of all available safety data of more than 17 million people vaccinated in the European Union and United Kingdom with Covid Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country", the company said in a statement.

Vaccination centres are being migrated to AstraZeneca for first doses, to maximise use of available Covid-19 vaccine supplies.

Norwegian officials said on Saturday the country had reports of people "bleeding under the skin" and "severe cases of blood clots or brain haemorrhages in younger people" who had received the shot.

In response to the suspensions of its vaccine, AstraZeneca said it had carefully reviewed the data on 17 million people who received doses across Europe.

Approximately one in five of the total vaccine doses given in Ireland so far have been the AstraZeneca formula, however, it was due to account for a much bigger share this week as the vaccination of medically vulnerable people was expected to be ramped up.

The World Health Organisation (WHO) said on Friday that there was "no reason not to use" the vaccine developed by Swedish-British laboratory AstraZeneca and Oxford University.

Indonesia authorised one of the world's first private vaccination programmes last month to run alongside its national drive, enabling firms to buy state-procured vaccines for their staff in the country.

"It has not been concluded that there is any link between the Covid-19 vaccine AstraZeneca and these cases".

"We have made huge progress in the United Kingdom in relation to the vaccine, so it is important that people continue to do that so we can leave lockdown in the rearview mirror and we can move on with our lives".

Australia has secured about 54 million doses of the AstraZeneca vaccine, with the majority to be produced by CSL in Melbourne.

She said the move to suspend the vaccine's use temporarily in Ireland should "increase public confidence" in the vaccination programme. The shots are considered experimental because the vaccines were only developed in the a year ago, so there is no long-term data for any of them.

"I spent all yesterday in our practice vaccinating with the Oxford/AstraZeneca vaccine - I would not be immunising my own patients unless I felt it was safe".

Both figures are also down on the 5,177 coronavirus cases and 82 deaths posted last Sunday, with the latter at their lowest since 50 were reported on 12 October.

A pharmacist prepares to administer the AstraZeneca COVID-19 vaccine at a community vaccination center in London on Friday. "But this may be more of a perception problem because every time there is a vaccine issue, we hear the name "AstraZeneca" soon after".

"The good news is that even though there are delays with AstraZeneca we won't be late with our vaccination programme in the first quarter", Breton said.

President Moon Jae-in has promised to deliver COVID-19 vaccines to 70 percent of Korea's 51 million-strong population by September.

Since then, European leaders have bitterly criticised the company and cast doubt on the vaccine's efficacy while at the same time blocking some exports of doses to destinations outside the European Union.